6.71
price down icon1.32%   -0.09
after-market 시간 외 거래: 6.71
loading
전일 마감가:
$6.80
열려 있는:
$6.79
하루 거래량:
223.87K
Relative Volume:
0.63
시가총액:
$346.83M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-12.66
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
-1.18%
1개월 성능:
-5.09%
6개월 성능:
+58.63%
1년 성능:
+51.47%
1일 변동 폭
Value
$6.65
$6.91
1주일 범위
Value
$6.64
$7.178
52주 변동 폭
Value
$3.19
$7.4899

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
명칭
Diamedica Therapeutics Inc
Name
전화
(763) 496-5454
Name
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
직원
28
Name
트위터
@diamedica
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
DMAC's Discussions on Twitter

DMAC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
6.71 351.48M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
628.00 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.47 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
831.48 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.77 39.72B 447.02M -1.18B -868.57M -6.1812

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-30 개시 TD Cowen Buy
2024-10-07 개시 H.C. Wainwright Buy
2024-04-24 재개 Craig Hallum Buy
2023-06-22 업그레이드 Oppenheimer Perform → Outperform
2021-04-09 개시 Oppenheimer Outperform
2021-02-17 개시 ROTH Capital Buy
2020-10-30 개시 Guggenheim Buy
2020-07-08 개시 Maxim Group Buy
2019-04-30 개시 Dougherty & Company Buy
2019-03-05 개시 Lake Street Buy
모두보기

Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스

pulisher
09:33 AM

Why Wall Street Experts Believe This Biotech Stock Represents a Major Opportunity - Barchart.com

09:33 AM
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Order flow analysis tools used on DiaMedica Therapeutics Inc.July 2025 Final Week & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why DiaMedica Therapeutics Inc. stock remains on watchlistsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

[Form 4] DiaMedica Therapeutics Inc. Insider Trading Activity - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

[Form 3] DiaMedica Therapeutics Inc. Initial Statement of Beneficial Ownership - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock attract ESG investorsInsider Buying & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is DiaMedica Therapeutics Inc. stock supported by innovation pipeline2025 Macro Impact & AI Powered Market Trend Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Visual analytics tools that track DiaMedica Therapeutics Inc. performanceJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will breakout in DiaMedica Therapeutics Inc. lead to full recoveryJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is DiaMedica Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What momentum shifts mean for DiaMedica Therapeutics Inc.2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How DiaMedica Therapeutics Inc. stock performs in stagflationJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Has DiaMedica Therapeutics Inc. formed a bullish divergenceMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock outperform tech sector in 20252025 Dividend Review & Safe Capital Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How institutional buying supports DiaMedica Therapeutics Inc. stock2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Developing predictive dashboards with DiaMedica Therapeutics Inc. dataEarnings Miss & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Short interest data insights for DiaMedica Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can DiaMedica Therapeutics Inc. stock hit analyst price targetsQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using economic indicators to assess DiaMedica Therapeutics Inc. potentialPortfolio Profit Report & Weekly Stock Performance Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is DiaMedica Therapeutics Inc. stock cheap at current valuation2025 Year in Review & Fast Moving Stock Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Backtesting results for DiaMedica Therapeutics Inc. trading strategiesJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionCEO Change & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can DiaMedica Therapeutics Inc. stock double in next 5 years2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 02:03:37 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated at TD Cowen - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Sector ETF performance correlation with DiaMedica Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:34:37 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Live market analysis of DiaMedica Therapeutics Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What valuation multiples suggest for DiaMedica Therapeutics Inc. stockJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com

Oct 31, 2025

Diamedica Therapeutics Inc (DMAC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Diamedica Therapeutics Inc 주식 (DMAC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
STAHLBERG JAN
10% Owner
Aug 13 '25
Buy
5.91
293,601
1,734,918
7,058,066
STAHLBERG JAN
10% Owner
Aug 14 '25
Buy
5.99
70,414
421,921
7,128,480
STAHLBERG JAN
10% Owner
Aug 20 '25
Buy
5.86
71,107
416,495
7,207,820
STAHLBERG JAN
10% Owner
Aug 26 '25
Buy
6.00
59,648
357,888
7,713,693
STAHLBERG JAN
10% Owner
Aug 22 '25
Buy
5.96
59,788
356,576
7,315,780
STAHLBERG JAN
10% Owner
Aug 27 '25
Buy
6.00
50,772
304,632
7,764,465
STAHLBERG JAN
10% Owner
Aug 21 '25
Buy
5.96
48,172
287,028
7,255,992
STAHLBERG JAN
10% Owner
Aug 15 '25
Buy
6.00
8,233
49,398
7,136,713
STAHLBERG JAN
10% Owner
Jul 23 '25
Buy
3.50
1,542,857
5,400,000
6,764,465
Von Koch Thomas
10% Owner
Jul 23 '25
Buy
3.50
2,857,142
9,999,997
8,383,577
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
자본화:     |  볼륨(24시간):